Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA Pharma and Ensho Therapeutics
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.eapharma.co.jp/hubfs/corporate/en/news/2024/0628.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
